HALISTER: Alexion Investigating Allegations on Sales Practices

Alexion Investigating Allegations on Sales Practices

(Bloomberg) -- Alexion says in filing to delay 10-Q that it’s investigating whether personnel engaged in sales practices that were inconsistent with company policies and procedures.
  • Audit and Finance Committee has retained outside counsel
  • Committee at this time hasn’t identified instances where Soliris orders weren’t placed by customers for patients, or any facts that require ALXN to update previously reported results
  • Allegations recently made by former employee
  • ALXN halted; share have fallen 33% YTD
  • NOTE: Nov. 4, Alexion 10-Q Filing Delayed, Something ‘Afoot’: Leerink Link
  • Filing: Link
Alert: HALISTER
Source: BFW (Bloomberg First Word)

Tickers
ALXN US (Alexion Pharmaceuticals Inc)

To de-activate this alert, click here

UUID: 7947283